{"news_desk": "Letters", "print_page": "24", "section_name": "Opinion", "subsection_name": null, "byline": [], "abstract": null, "type_of_material": "Letter", "word_count": "470", "lead_paragraph": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "pub_date": "2016-02-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "For Some Diabetics, a Struggle to Pay for Insulin", "content_kicker": "Letters", "print_headline": "For Some Diabetics, a Struggle to Pay for Insulin", "kicker": "Letters"}, "snippet": "The drug company Eli Lilly and an organization that helps diabetics discuss rising treatment costs.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/29/opinion/for-some-diabetics-a-struggle-to-pay-for-insulin.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Diabetes", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Insulin", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Eli Lilly and Company", "name": "organizations"}], "blog": [], "_id": "56d3ff7638f0d86ef22e18be", "source": "The New York Times"}